Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weisman

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Rheumatology|February 13, 2002
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritisUrsula Mason, Jose Aldrich, Ferdinand Breedveld, et al.
Arthritis and Rheumatism|May 29, 2007
Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohortsHye-Soon Lee, Patricia Irigoyen, Marlena Kern, et al.
Arthritis Care & Research|March 2, 2010
Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosusElizabeth R Volkmann, Jennifer M Grossman, Lori J Sahakian, et al.
Arthritis and Rheumatism|August 1, 2009
Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosusMaureen McMahon, Jennifer Grossman, Brian Skaggs, et al.
Annals of the Rheumatic Diseases|June 15, 2011
High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipidsMaureen McMahon, Brian J Skaggs, Lori Sahakian, et al.
The Journal of Rheumatology|December 3, 2010
Current controversies in spondyloarthritis: SPARTANMichael Weisman, Thomas J Learch, Xenofon Baraliakos, et al.
Arthritis and Rheumatism|December 2, 2005
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope allelesPatricia Irigoyen, Annette T Lee, Mark H Wener, et al.
Plos Genetics|December 15, 2010
Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's diseasePatrick Danoy, Karena Pryce, Johanna Hadler, et al.
Annals of the Rheumatic Diseases|April 7, 2007
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite studyDaniel E Furst, Norman Gaylis, Vance Bray, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosusJyotsna Bhattacharya, Karalyn Pappas, Bahtiyar Toz, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Rheumatology|February 13, 2002
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritisUrsula Mason, Jose Aldrich, Ferdinand Breedveld, et al.
Arthritis and Rheumatism|May 29, 2007
Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohortsHye-Soon Lee, Patricia Irigoyen, Marlena Kern, et al.
Arthritis Care & Research|March 2, 2010
Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosusElizabeth R Volkmann, Jennifer M Grossman, Lori J Sahakian, et al.
Arthritis and Rheumatism|August 1, 2009
Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosusMaureen McMahon, Jennifer Grossman, Brian Skaggs, et al.
Annals of the Rheumatic Diseases|June 15, 2011
High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipidsMaureen McMahon, Brian J Skaggs, Lori Sahakian, et al.
The Journal of Rheumatology|December 3, 2010
Current controversies in spondyloarthritis: SPARTANMichael Weisman, Thomas J Learch, Xenofon Baraliakos, et al.
Arthritis and Rheumatism|December 2, 2005
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope allelesPatricia Irigoyen, Annette T Lee, Mark H Wener, et al.
Plos Genetics|December 15, 2010
Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's diseasePatrick Danoy, Karena Pryce, Johanna Hadler, et al.
Annals of the Rheumatic Diseases|April 7, 2007
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite studyDaniel E Furst, Norman Gaylis, Vance Bray, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosusJyotsna Bhattacharya, Karalyn Pappas, Bahtiyar Toz, et al.
Pageof 7